Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
860 studies found for:    Open Studies | "Prostatic Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
Conditions: Prostate Cancer;   Prostatic Neoplasms
Interventions: Drug: Panobinostat;   Drug: Bicalutamide
22 Recruiting Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy
Conditions: Prostate Cancer;   Prostatic Neoplasms;   Neoplasms, Prostate
Interventions: Biological: PROSTVAC-V/TRICOM;   Biological: PROSTVAC-F/TRICOM
23 Not yet recruiting An Efficacy and Safety Study of JNJ56021927 in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)
Condition: Prostatic Neoplasms
Interventions: Drug: JNJ56021927;   Drug: Abiraterone acetate;   Drug: Prednisone;   Drug: Placebo
24 Recruiting Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Condition: Prostatic Neoplasms
Intervention: Drug: Radium-223 dichloride (BAY88-8223)
25 Unknown  CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS)
Condition: Prostatic Neoplasms
Interventions: Drug: Docetaxel;   Drug: Temsirolimus
26 Recruiting Atorvastatin and Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Atorvastatin;   Drug: Placebo
27 Recruiting Lyophilized Black Raspberry in Treating Patients With Prostate Cancer Undergoing Surgery
Conditions: Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: lyophilized black raspberry lozenge;   Other: laboratory biomarker analysis;   Dietary Supplement: dietary intervention;   Procedure: therapeutic conventional surgery;   Procedure: quality-of-life assessment;   Other: questionnaire administration
28 Recruiting MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Prostatic Diseases
Intervention:
29 Recruiting Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions: Drug: Docetaxel;   Dietary Supplement: Lycopene
30 Not yet recruiting Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery
Conditions: Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Dietary Supplement: dietary intervention (tangerine tomato juice);   Dietary Supplement: dietary intervention (red tomato juice);   Other: questionnaire administration;   Other: Correlative studies
31 Recruiting Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial
Condition: Prostatic Neoplasm
Intervention: Radiation: Pd-103
32 Recruiting Prostatic Cancer Versus Androgen Deficiency
Condition: Cancer of Prostate
Intervention: Other: Blood sample
33 Recruiting Evaluation of Diagnostic Value of 3-T Magnetic Resonance Imaging (MRI) in Suspected Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Device: magnetic resonance imaging, Siemens
34 Unknown  Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: Samarium Sm-153 lexidronam + Docetaxel
35 Recruiting Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: CT-011 (Anti-PD1 Antibody);   Other: Sipuleucel-T (Provenge);   Drug: Cyclophosphamide
36 Recruiting A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)
Condition: Prostate Neoplasms
Interventions: Drug: Abiraterone acetate;   Drug: Prednisone;   Other: Androgen deprivation therapy (ADT);   Drug: Abiraterone acetate Placebo;   Drug: Prednisone Placebo
37 Not yet recruiting Single Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II Trial
Condition: Prostatic Neoplasms
Intervention: Radiation: HDR brachytherapy + hypofractionated EBRT
38 Recruiting Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: METFORMIN;   Drug: Placebo;   Drug: TAXOTERE®
39 Recruiting First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Biological: BAY2010112
40 Recruiting A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostrate Cancer and Men With Metastatic Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Castration-resistant Prostate Cancer
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years